LPL Financial
RVMD icon

LPL Financial’s Revolution Medicines RVMD Stock Holding History

LPL Financial’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6M Buy
67,500
+44,881
+198% +$6.56M ﹤0.01% 1930
2026
Q1 		$2.2M Buy
22,619
+6,832
+43% +$690K ﹤0.01% 3416
2025
Q4 		$1.26M Buy
15,787
+9,928
+169% +$651K ﹤0.01% 3832
2025
Q3 		$274K Buy
+5,859
New +$229K ﹤0.01% 5123
2025
Q1 		– Sell
-10,318
Closed -$451K – 5488
2024
Q4 		$451K Sell
10,318
-4,212
-29% -$213K ﹤0.01% 4188
2024
Q3 		$659K Buy
14,530
+8,418
+138% +$367K ﹤0.01% 3768
2024
Q2 		$237K Buy
+6,112
New +$228K ﹤0.01% 4438

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

LPL Financial's RVMD Position: Q2 2026 in Review

LPL Financial increased its Revolution Medicines (RVMD) stake by 198% in Q2 2026, buying an estimated $6.56M and bringing the position to 67,500 shares worth $12.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1930.

LPL Financial first reported a position in RVMD in Q2 2024 and has held it in 7 quarters since. 692 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • LPL Financial held 67,500 shares of Revolution Medicines worth $12.6M as of Q2 2026.
  • LPL Financial bought 44,881 Revolution Medicines shares in Q2 2026, an estimated $6.56M.
  • Revolution Medicines made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #1930 holding.
  • LPL Financial first reported a position in Revolution Medicines in Q2 2024 and has held it in 7 quarters since.
  • 692 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.